Answer
Pembrolizumab has a minor influence on the ability to drive and use machines, with dizziness and fatigue reported in some patients following administration.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 67Document updated
Sources checked